Medtronic
MDT
1,284 hedge funds and large institutions have $91B invested in Medtronic in 2017 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 459 increasing their positions, 546 reducing their positions, and 86 closing their positions.
38% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 86
13% more capital invested
Capital invested by funds: $80.7B → $91B (+$10.3B)
1% more funds holding
Funds holding: 1,268 → 1,284 (+16)
0.04% more ownership
Funds ownership: 82.47% → 82.51% (+0.04%)
6% less funds holding in top 10
Funds holding in top 10: 50 → 47 (-3)
16% less repeat investments, than reductions
Existing positions increased: 459 | Existing positions reduced: 546
24% less call options, than puts
Call options by funds: $324M | Put options by funds: $424M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.54B |
| 2 |
Lazard Asset Management
New York
|
+$1.13B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$345M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$269M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$210M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$831M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$508M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$286M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$176M |
| 5 |
Two Sigma Investments
New York
|
-$152M |
MDT Hedge Fund Activity: Q1 2017 in Review
1,284 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2017, worth a combined $91B — up 13% from $80.7B a quarter earlier.
Buyers outnumbered sellers: 119 funds opened new MDT positions and 86 closed out — a net gain of 33 holders — while 459 added to existing stakes and 546 trimmed.
The largest buyer was BlackRock, adding an estimated $6.54B. The largest seller was Capital World Investors, cutting an estimated $831M.
- 1,284 institutional investors held Medtronic (MDT) as of Q1 2017, up from 1,268 in Q4 2016.
- Funds reported $91B of Medtronic stock for Q1 2017, up 13% quarter-over-quarter.
- 119 funds opened new Medtronic positions in Q1 2017 and 86 closed out, a net change of +33 holders.
- The largest Medtronic buyer in Q1 2017 was BlackRock, an estimated $6.54B added.
- The largest Medtronic seller in Q1 2017 was Capital World Investors, an estimated $831M sold.
Based on aggregated 13F filings for Q1 2017.